Search hospitals > Florida > Tampa
University of South Florida
Claim this profileTampa, Florida 33612
Global Leader in Multiple Sclerosis
Global Leader in Parkinson's Disease
Conducts research for Human Immunodeficiency Virus Infection
Conducts research for HIV/AIDS
Conducts research for Alzheimer's Disease
633 reported clinical trials
61 medical researchers
Summary
University of South Florida is a medical facility located in Tampa, Florida. This center is recognized for care of Multiple Sclerosis, Parkinson's Disease, Human Immunodeficiency Virus Infection, HIV/AIDS, Alzheimer's Disease and other specialties. University of South Florida is involved with conducting 633 clinical trials across 619 conditions. There are 61 research doctors associated with this hospital, such as Juan F. Rico, Maxim Mokin, PhD, Yarema Bezchlibnyk, MD, and Murray Shames, MD.Area of expertise
1Multiple Sclerosis
Global Leader2Parkinson's Disease
Global LeaderStage I
Stage II
Top PIs
Juan F. RicoTampa General Hospital7 years of reported clinical research
Expert in Tumors
Studies Cancer
29 reported clinical trials
80 drugs studied
Maxim Mokin, PhDTampa General Hospital3 years of reported clinical research
Studies Stroke
Studies Ischemic Stroke
7 reported clinical trials
12 drugs studied
Yarema Bezchlibnyk, MDTampa General Hospital5 years of reported clinical research
Studies Alzheimer's Disease
Studies Dystonia
6 reported clinical trials
7 drugs studied
Murray Shames, MDTampa General Hospital3 years of reported clinical research
Studies Aortic Aneurysm
Studies Thoracic Aortic Aneurysm
6 reported clinical trials
5 drugs studied
Clinical Trials running at University of South Florida
Multiple Sclerosis
Migraine
Heart Failure
Ischemic Stroke
Stroke
Syndrome
Hearing Loss
Cardiomyopathy
Nephrotic Syndrome
Pulmonary Arterial Hypertension
Ofatumumab
for Multiple Sclerosis
The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).
Recruiting2 awards Phase 3
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares remibrutinib and teriflunomide in patients with relapsing multiple sclerosis. It aims to find out which medication is more effective and safer. Both drugs work by controlling the immune system to reduce relapses. Teriflunomide is an approved treatment for adults with this condition.
Recruiting2 awards Phase 3
Rho Kinase Inhibitor
for ALS
This trial is testing a new drug called WP-0512 to see if it can help people with ALS. It targets patients who have had ALS symptoms for a few years and meet specific health criteria. The drug aims to slow down the progression of ALS symptoms.
Recruiting1 award Phase 29 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of South Florida?
University of South Florida is a medical facility located in Tampa, Florida. This center is recognized for care of Multiple Sclerosis, Parkinson's Disease, Human Immunodeficiency Virus Infection, HIV/AIDS, Alzheimer's Disease and other specialties. University of South Florida is involved with conducting 633 clinical trials across 619 conditions. There are 61 research doctors associated with this hospital, such as Juan F. Rico, Maxim Mokin, PhD, Yarema Bezchlibnyk, MD, and Murray Shames, MD.
Where is University of South Florida located?
**Directions to University of South Florida Hospital, Tampa, FL:**
- From I-275, take exit 51 (SR 582, Fowler Ave) and head east on Fowler Ave for approximately 3 miles. The main entrance to the university will be on your left.
- For the USF Health Morsani Center for Advanced Healthcare, visit 13330 USF Laurel Drive, Tampa, FL 33612.
Who should I call to ask about financial aid or insurance network?
**University of South Florida (USF) Hospital Contact Information**
**Financial Assistance:**
- **Address:** USF Health Financial Aid Office, The WELL 12901 Bruce B. Downs Blvd. Tampa, FL 33612-4799
- **Phone:** (813) 821-8038
- **Email:** Secure online email system
**Insurance:**
- **Phone:** (813) 821-8038
- **Email:** Secure online email system
**Billing:**
- **Phone:** (813) 821-8004
- **Address:** UMSA (University Medical Services Association) P.O. Box 917689 Orlando, FL 32891-7689
What insurance does University of South Florida accept?
The University of South Florida (USF) accepts a variety of health insurance plans for medical services, including those offered by the State of Florida and private insurance companies. Accepted insurance plans include:
- **State of Florida Health Insurance Plans**: Health, dental, vision, cancer and intensive care coverage, supplemental hospital insurance, accident/disability insurance, and flexible spending accounts through People First.
- **Academic HealthPlans (AHP)**: The USF Student Health Insurance Plan, administered by AHP and provided by Aetna, is available to eligible Graduate Assistants/Associates, with premiums potentially covered by the university.
- **Private Insurance Companies**: Aetna, AvMed, Blue Cross Blue Shield, Cigna, Humana, Medicaid, Multiplan, Tricare, United Healthcare, and Vista Healthplan.
Patients are advised to confirm their plan’s acceptance when making an appointment and are responsible for any non-covered costs.
What awards or recognition has University of South Florida received?
The University of South Florida (USF) in Tampa, Florida, is a "Preeminent State Research University" and a "Doctoral University with 'Very High Research Activity'" as recognized by the Carnegie Foundation. In fiscal year 2023, USF received $692 million in research contracts and grants. The institution also supports its residents and fellows through the Graduate Medical Education Research Grant Program, allocating up to $50,000 for approved research and quality improvement projects.